130 related articles for article (PubMed ID: 30681440)
1. Chronic Ovine Studies Demonstrate Low Thromboembolic Risk in the Penn State Infant Ventricular Assist Device.
Lukic B; Clark JB; Izer JM; Cooper TK; Finicle HA; Cysyk J; Doxtater B; Yeager E; Reibson J; Newswanger RK; Leibich P; Bletcher K; Weiss WJ
ASAIO J; 2019; 65(4):371-379. PubMed ID: 30681440
[TBL] [Abstract][Full Text] [Related]
2. Chronic in vivo testing of the Penn State infant ventricular assist device.
Weiss WJ; Carney EL; Clark JB; Peterson R; Cooper TK; Nifong TP; Siedlecki CA; Hicks D; Doxtater B; Lukic B; Yeager E; Reibson J; Cysyk J; Rosenberg G; Pierce WS
ASAIO J; 2012; 58(1):65-72. PubMed ID: 22157073
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
4. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism.
Rose EA; Levin HR; Oz MC; Frazier OH; Macmanus Q; Burton NA; Lefrak EA
Circulation; 1994 Nov; 90(5 Pt 2):II87-91. PubMed ID: 7955291
[TBL] [Abstract][Full Text] [Related]
5. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
[TBL] [Abstract][Full Text] [Related]
6. Bleeding and thrombotic events occur early in children on durable ventricular assist devices.
Huang JY; Ignjatovic V; Sheridan BJ; Mathew J; D'Udekem Y; Brink J; Barton R; Callea G; Morsman D; Donath S; Opat S; Monagle P
Thromb Res; 2019 Jan; 173():65-70. PubMed ID: 30476715
[TBL] [Abstract][Full Text] [Related]
7. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices.
Slater JP; Rose EA; Levin HR; Frazier OH; Roberts JK; Weinberg AD; Oz MC
Ann Thorac Surg; 1996 Nov; 62(5):1321-7; discussion 1328. PubMed ID: 8893563
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
[TBL] [Abstract][Full Text] [Related]
9. Analysis of platelet function during left ventricular support with the Incor and Excor system.
Etz C; Welp H; Rothenburger M; Tjan TD; Wenzelburger F; Schmidt C; Scheld HH; Schmid C
Heart Surg Forum; 2004; 7(5):E423-7. PubMed ID: 15799917
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
11. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
Lee CL; Colombo PC; Eisenberger A; Diuguid D; Jennings DL; Han J; Salna MP; Takeda K; Kurlansky PA; Yuzefpolskaya M; Garan AR; Naka Y; Takayama H
Ann Thorac Surg; 2018 Jan; 105(1):122-128. PubMed ID: 28987395
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
[TBL] [Abstract][Full Text] [Related]
13. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
[TBL] [Abstract][Full Text] [Related]
14. A method for anticoagulation of children on mechanical circulatory support.
Copeland H; Nolan PE; Covington D; Gustafson M; Smith R; Copeland JG
Artif Organs; 2011 Nov; 35(11):1018-23. PubMed ID: 22097979
[TBL] [Abstract][Full Text] [Related]
15. Animal model development for the Penn State pediatric ventricular assist device.
Carney EL; Clark JB; Myers JL; Peterson R; Wilson RP; Weiss WJ
Artif Organs; 2009 Nov; 33(11):953-7. PubMed ID: 19849686
[TBL] [Abstract][Full Text] [Related]
16. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
17. Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity.
Chiu WC; Tran PL; Khalpey Z; Lee E; Woo YR; Slepian MJ; Bluestein D
Sci Rep; 2019 Feb; 9(1):2946. PubMed ID: 30814674
[TBL] [Abstract][Full Text] [Related]
18. Developing an Anti-Xa-Based Anticoagulation Protocol for Patients with Percutaneous Ventricular Assist Devices.
Sieg A; Mardis BA; Mardis CR; Huber MR; New JP; Meadows HB; Cook JL; Toole JM; Uber WE
ASAIO J; 2015; 61(5):502-8. PubMed ID: 26273933
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
[TBL] [Abstract][Full Text] [Related]
20. Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
Pacholewicz J; Kuliczkowski W; Kaczmarski J; Zakliczyński M; Garbacz M; Zembala M; Serebruany V
Cardiology; 2015; 131(3):172-6. PubMed ID: 25967953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
